誉衡药业 (002437.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(誉衡药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度销售毛利率(%) 52.0054.0054.00-14.0078.0080.0078.00
 单季度销售净利率(%) 9.0012.009.00-18.0032.001.003.00
 单季度净资产收益率ROE(%) 3.004.003.00-6.0011.00-1.00
 单季度总资产净利率ROA(%) 2.003.002.00-3.006.00-1.00
单季度财务摘要:
 单季度营业总收入(元) 636,196,066.00628,177,345.00593,133,302.00574,030,802.00619,345,304.00751,494,230.00681,168,971.00
 单季度营业总成本(元) 578,203,460.00554,915,060.00553,364,313.00552,257,245.00597,047,969.00703,614,746.00636,373,987.00
 单季度营业收入(元) 636,196,066.00628,177,345.00593,133,302.00574,030,802.00619,345,304.00751,494,230.00681,168,971.00
 单季度营业利润(元) 69,034,913.0084,817,031.0068,449,053.00-85,363,083.00209,038,314.0019,155,178.0032,216,203.00
 单季度利润总额(元) 68,988,652.0084,655,681.0068,413,554.00-83,419,704.00208,817,033.0019,367,355.0032,013,465.00
 单季度净利润(元) 60,260,538.0075,764,743.0055,761,035.00-102,360,437.00198,778,029.0010,412,604.0021,870,445.00
 单季度归属母公司股东的净利润(元) 58,514,996.0072,687,857.0052,282,910.00-103,289,363.00195,374,523.008,190,429.0020,058,599.00
 单季度经营活动产生的现金流量(元) 98,610,556.0042,652,298.00159,239,649.00-32,965,260.00104,669,796.00118,771,382.0083,699,367.00
 单季度投资活动产生的现金流量(元) -3,007,567.002,912,031.00-4,756,665.00-13,380,895.0065,477,898.0017,135,498.0025,147,232.00
 单季度筹资活动产生的现金流量(元) -59,656,820.00-312,796,555.00-164,988,138.00-178,333,623.00-208,889,873.00-400,677,121.00-101,258,940.00
 单季度现金及现金等价物净增加(元) 34,881,744.00-266,950,390.00-10,396,994.00-225,535,365.00-39,088,774.00-261,808,770.006,815,714.00

前瞻产业研究院